Maximum quantity allowed is 999
CAS RN: 131707-23-8 | Product Number: A3402
Arbidol Hydrochloride

Purity: >98.0%(HPLC)
- Ethyl 6-Bromo-4-[(dimethylamino)methyl]-5-hydroxy-1-methyl-2-[(phenylthio)methyl]-1H-indole-3-carboxylate Hydrochloride
* The above prices include freight cost, customs, and other charges to the destination except for products that need to be shipped by sea or dry ice. For details, please contact
our distributor
in Taiwan to order our product.
* The storage conditions are subject to change without notice.
Supplemental Product Information:
This product is a sample for RUO (research use only). Do not use this product for any purpose other than testing and research.
Product Number | A3402 |
Purity / Analysis Method | >98.0%(HPLC) |
Molecular Formula / Molecular Weight | C__2__2H__2__5BrN__2O__3S·HCl = 513.88 |
Physical State (20 deg.C) | Solid |
Storage Temperature | Room Temperature (Recommended in a cool and dark place, <15°C) |
Packaging and Container | 100MG-Glass Bottle with Plastic Insert (View image) |
CAS RN | 131707-23-8 |
Reaxys Registry Number | 5469513 |
PubChem Substance ID | 468590279 |
MDL Number | MFCD00344795 |
Appearance | White to Light yellow powder to crystal |
Purity(HPLC) | min. 98.0 area% |
Purity(Nonaqueous Titration) | min. 96.0 % |
Melting Point | 142 °C |
RTECS# | NL5998075 |
H.S.code* | 2933.99-000 |
References
- 1) Arbidol: a broad-spectrum antiviral compound that blocks viral fusion (a review)
- 2) Arbidol as a broad-spectrum antiviral: An update (a review)
- 3) Arbidol and other low-molecular-weight drugs that inhibit Lassa and Ebola viruses
- 4) Arbidol: A potential antiviral drug for the treatment of SARS-CoV-2 by blocking trimerization of the spike glycoprotein
- 5) Candidate drugs against SARS-CoV-2 and COVID-19 (a review)
Documents
Safety Data Sheet (SDS)
The requested SDS is not available.
Please Contact Us for more information.
Specifications
C of A & Other Certificates
Sample C of A
A sample C of A for this product is not available at this time.
Analytical Charts
The requested analytical chart is not available. Sorry for the inconvenience.